Abstract
Antide is the decapeptide N-Ac-D-Nal(2),D-Phe(pCl),D-Pal(3),Ser,Lys(Nic),D-Lys(Nic),Leu,Lys(iPr),P ro,D- Ala-NH2 [Nal(2) represents 3-(2-naphthyl)alanine; Phe(p-Cl) represents 3-(4-chlorophenyl)alanine; Pal(3) represents 3-(3-pyridyl)alanine; Lys(Nic) represents N epsilon-nicotinoyllysine; Lys-(iPr) represents N epsilon-isopropyllysine], which is an antagonist of luteinizing hormone-releasing hormone (LHRH), which has high antiovulatory activity, releases negligible histamine, and is scheduled for scale-up, safety testing, and evaluation in the experimental primate and in clinical medicine. Thirty-five more peptides were synthesized, designed on antide with variations in positions 5-8. Of these, N-Ac-D-Nal(2),D-Phe(pCl),D-Pal(3),Ser,Lys(Pic),cis-D- Ala(PzAC),Leu,Lys(iPr),Pro,D-Ala-NH2 [Lys(Pic) represents N epsilon-picoloyllysine; Ala(PzAC) represents 3-(4-pyrazinylcarbonylaminocyclohexyl)alanine] was not only the most potent but also had higher antiovulatory activity than antide--i.e., 73% per 0.25 microgram and 100% per 0.5 microgram vs. 36% per 0.5 microgram and 100% per 1.0 microgram. Antide showed significant (P less than 0.001) duration of action when injected at a dose of 10 micrograms 44 hr before injection of 50 ng of the agonist [D-Qal(3)6]LHRH [Qal(3) represents 3-(3-quinolyl)alanine]. Antide showed oral antiovulatory activity at 600 micrograms (73%) and at 1200 micrograms (100%) with negligible difference between water and corn oil oral formulations.
Full text
PDF




Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Bajusz S., Kovacs M., Gazdag M., Bokser L., Karashima T., Csernus V. J., Janaky T., Guoth J., Schally A. V. Highly potent antagonists of luteinizing hormone-releasing hormone free of edematogenic effects. Proc Natl Acad Sci U S A. 1988 Mar;85(5):1637–1641. doi: 10.1073/pnas.85.5.1637. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Folkers K., Bowers C. Y., Shieh H. M., Liu Y. Z., Xiao S. B., Tang P. F., Chu J. Y. Antagonists of the luteinizing hormone releasing hormone (LHRH) with emphasis on the TRP7 of the salmon and chicken II LHRH's. Biochem Biophys Res Commun. 1984 Sep 28;123(3):1221–1226. doi: 10.1016/s0006-291x(84)80263-6. [DOI] [PubMed] [Google Scholar]
- Hocart S. J., Nekola M. V., Coy D. H. Effect of reductive alkylation of D-lysine in position 6 on the histamine-releasing activity of luteinizing hormone-releasing hormone antagonists. J Med Chem. 1987 Apr;30(4):739–743. doi: 10.1021/jm00387a030. [DOI] [PubMed] [Google Scholar]
- Humphries J., Wan Y. P., Folkers K., Bowers C. Y. Inhibitory analogues of the luteinizing hormone-releasing hormone having D-aromatic residues in positions 2 and 6 and variation in position 3. J Med Chem. 1978 Jan;21(1):120–123. doi: 10.1021/jm00199a024. [DOI] [PubMed] [Google Scholar]
- Karten M. J., Rivier J. E. Gonadotropin-releasing hormone analog design. Structure-function studies toward the development of agonists and antagonists: rationale and perspective. Endocr Rev. 1986 Feb;7(1):44–66. doi: 10.1210/edrv-7-1-44. [DOI] [PubMed] [Google Scholar]
- Ljungqvist A., Feng D. M., Tang P. F., Kubota M., Okamoto T., Zhang Y. W., Bowers C. Y., Hook W. A., Folkers K. Design, synthesis and bioassays of antagonists of LHRH which have high antiovulatory activity and release negligible histamine. Biochem Biophys Res Commun. 1987 Oct 29;148(2):849–856. doi: 10.1016/0006-291x(87)90953-3. [DOI] [PubMed] [Google Scholar]
- Miyamoto K., Hasegawa Y., Nomura M., Igarashi M., Kangawa K., Matsuo H. Identification of the second gonadotropin-releasing hormone in chicken hypothalamus: evidence that gonadotropin secretion is probably controlled by two distinct gonadotropin-releasing hormones in avian species. Proc Natl Acad Sci U S A. 1984 Jun;81(12):3874–3878. doi: 10.1073/pnas.81.12.3874. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Nekola M. B., Horvath A., Ge L. J., Coy D. H., Schally A. V. Suppression of ovulation in the rat by an orally active antagonist of luteinizing hormone-releasing hormone. Science. 1982 Oct 8;218(4568):160–162. doi: 10.1126/science.6750790. [DOI] [PubMed] [Google Scholar]
- Nestor J. J., Jr, Tahilramani R., Ho T. L., McRae G. I., Vickery B. H. Potent, long-acting luteinizing hormone-releasing hormone antagonists containing new synthetic amino acids: N,N'-dialkyl-D-homoarginines. J Med Chem. 1988 Jan;31(1):65–72. doi: 10.1021/jm00396a011. [DOI] [PubMed] [Google Scholar]
- Rivier J. E., Porter J., Rivier C. L., Perrin M., Corrigan A., Hook W. A., Siraganian R. P., Vale W. W. New effective gonadotropin releasing hormone antagonists with minimal potency for histamine release in vitro. J Med Chem. 1986 Oct;29(10):1846–1851. doi: 10.1021/jm00160a008. [DOI] [PubMed] [Google Scholar]
- Rivier J., Kupryszewski G., Varga J., Porter J., Rivier C., Perrin M., Hagler A., Struthers S., Corrigan A., Vale W. Design of potent cyclic gonadotropin releasing hormone antagonists. J Med Chem. 1988 Mar;31(3):677–682. doi: 10.1021/jm00398a030. [DOI] [PubMed] [Google Scholar]
- Sherwood N. M., Sower S. A., Marshak D. R., Fraser B. A., Brownstein M. J. Primary structure of gonadotropin-releasing hormone from lamprey brain. J Biol Chem. 1986 Apr 15;261(11):4812–4819. [PubMed] [Google Scholar]
- Sherwood N., Eiden L., Brownstein M., Spiess J., Rivier J., Vale W. Characterization of a teleost gonadotropin-releasing hormone. Proc Natl Acad Sci U S A. 1983 May;80(9):2794–2798. doi: 10.1073/pnas.80.9.2794. [DOI] [PMC free article] [PubMed] [Google Scholar]
